ARRDC3 and cancer: Several publications have associated abnormalities in ARRDC3 with a wide variety of cancers, particularly in epithelial to mesenchymal transition (EMT) and invasiveness, where loss/downregulation of ARRDC3 contributes to more severe phenotypes [22–28].